These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3772504)

  • 1. Iodine-131 metaiodobenzylguanidine scintigraphy of carcinoid tumors.
    Feldman JM; Blinder RA; Lucas KJ; Coleman RE
    J Nucl Med; 1986 Nov; 27(11):1691-6. PubMed ID: 3772504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoid tumors: iodine-131 MIBG scintigraphy.
    Hanson MW; Feldman JM; Blinder RA; Moore JO; Coleman RE
    Radiology; 1989 Sep; 172(3):699-703. PubMed ID: 2772175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of 131I-metaiodobenzylguanidine scintigraphy in the diagnosis of intestinal carcinoids].
    Bihl H; Sautter-Bihl ML; Wilhelm KR; Kimmig B
    Nuklearmedizin; 1987 Dec; 26(6):263-7. PubMed ID: 3438170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of carcinoid tumors with iodine-123 metaiodobenzylguanidine.
    Bomanji J; Levison DA; Zuzarte J; Britton KE
    J Nucl Med; 1987 Dec; 28(12):1907-10. PubMed ID: 3681447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma.
    Von Moll L; McEwan AJ; Shapiro B; Sisson JC; Gross MD; Lloyd R; Beals E; Beierwaltes WH; Thompson NW
    J Nucl Med; 1987 Jun; 28(6):979-88. PubMed ID: 3035114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.
    Bomanji J; Mather S; Moyes J; Ellison D; Grossman A; Britton KE; Besser GM
    J Nucl Med; 1992 Jun; 33(6):1121-4. PubMed ID: 1597726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contribution of 131I MIBG scintigraphy in the diagnosis of carcinoid tumors of the digestive tract. Experience of 14 cases].
    Siproudhis L; Lescouarc'h J; Bretagne JF; Bourguet P; Raoul JL; Etienne PL; Herry JY; Gosselin M
    Gastroenterol Clin Biol; 1991; 15(11):789-93. PubMed ID: 1769467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unsuccessful iodine-131 MIBG imaging of carcinoid tumors and apudomas.
    Sinzinger H; Renner F; Granegger S
    J Nucl Med; 1986 Jul; 27(7):1221-2. PubMed ID: 3723196
    [No Abstract]   [Full Text] [Related]  

  • 9. [Iodine-131 metaiodobenzylguanidine and carcinoid tumors].
    Siproudhis L; Bretagne JF; Nicol L; Lebodic MF; Bourguet P; Kernec J; Lancien G; Herry JY; Gastard J
    Gastroenterol Clin Biol; 1987; 11(8-9):612-4. PubMed ID: 3653624
    [No Abstract]   [Full Text] [Related]  

  • 10. Carcinoid tumors: CT and I-131 meta-iodo-benzylguanidine scintigraphy.
    Adolph JM; Kimmig BN; Georgi P; zum Winkel K
    Radiology; 1987 Jul; 164(1):199-203. PubMed ID: 3588904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute liver necrosis induced by iodine-131-MIBG in the treatment of metastatic carcinoid tumors.
    Bongers V; de Klerk JM; Zonnenberg BA; de Kort G; Lips CJ; van Rijk PP
    J Nucl Med; 1997 Jul; 38(7):1024-6. PubMed ID: 9225784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors.
    Taal BG; Hoefnagel CA; Valdes Olmos RA; Boot H; Beijnen JH
    J Clin Oncol; 1996 Jun; 14(6):1829-38. PubMed ID: 8656251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours.
    Taal BG; Hoefnagel CA; Valdés Olmos RA; Boot H
    Eur J Cancer; 1996 Oct; 32A(11):1924-32. PubMed ID: 8943676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors.
    Lastoria S; Maurea S; Vergara E; Acampa W; Varrella P; Klain M; Muto P; Bernardy JD; Salvatore M
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):145-9. PubMed ID: 9002775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of 131I-MIBG in the imaging of metastatic carcinoid tumours.
    Jodrell DI; Irvine AT; McCready VR; Woodcraft E; Smith IE
    Br J Cancer; 1988 Nov; 58(5):663-4. PubMed ID: 3219278
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis and treatment of a carcinoid tumor using iodine-131 meta-iodobenzylguanidine.
    Hoefnagel CA; Den Hartog Jager FC; Van Gennip AH; Marcuse HR; Taal BG
    Clin Nucl Med; 1986 Mar; 11(3):150-2. PubMed ID: 3956021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presurgical diagnosis of a primary carcinoid tumor of the thymus with MIBG.
    Hirano T; Otake H; Watanabe N; Oriuchi N; Zennyouji A; Fukuda T; Endo K
    J Nucl Med; 1995 Dec; 36(12):2243-5. PubMed ID: 8523113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours.
    Nocaudie-Calzada M; Huglo D; Carnaille B; Proye C; Marchandise X
    Eur J Nucl Med; 1996 Nov; 23(11):1448-54. PubMed ID: 8854840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scintigraphic imaging of carcinoid tumours with 131I-metaiodobenzylguanidine.
    Fischer M; Kamanabroo D; Sonderkamp H; Proske T
    Lancet; 1984 Jul; 2(8395):165. PubMed ID: 6146062
    [No Abstract]   [Full Text] [Related]  

  • 20. [Carcinoid tumor metastases visualized by I-MIBG. Report of 5 cases].
    Mey P; Minier JF
    Ann Radiol (Paris); 1990; 33(4-5):237-9. PubMed ID: 2268126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.